SCHEMBL29660769

SCHEMBL29660769

CCOC(=O)c1sc(C2CC2)nc1C=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.44
GAA P10253 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HTT P42858 2/20 0.44
TSHR P16473 1/20 0.44
CASP3 P42574 1/20 0.42
DHODH Q02127 3/20 0.41
CYP1A2 P05177 1/20 0.41
HPGD P15428 7/20 0.40
KDM4E B2RXH2 4/20 0.40
MAPT P10636 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
RCE1 Q9Y256 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25242860 0.80 ALDH1A1 (0.46) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL29030796 0.80 ALDH1A1 (0.46) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL22900481 0.78 ALDH1A1 (0.46) ALDH1A1GAAHSD17B10DHODHCYP1A2
SCHEMBL29030782 0.77 ALDH1A1 (0.42) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL3402437 0.77 ALDH1A1 (0.65) ALDH1A1GAAHSD17B10CYP1A2HPGD
SCHEMBL4762073 0.76 CASP3 (0.51) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL29030786 0.76 ALDH1A1 (0.46) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL29660827 0.74 ALDH1A1 (0.43) ALDH1A1GAAHSD17B10CYP1A2HPGD
SCHEMBL12474720 0.74 CASP3 (0.49) ALDH1A1GAAHSD17B10HTTTSHR
SCHEMBL26847988 0.74 CASP3 (0.52) ALDH1A1GAAHSD17B10HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043450-A1 NEW COMPOUND JANSSEN PHARMACEUTICA NV (BE) 2024-02-08 US disclosed
EP-4217347-A1 NEW COMPOUNDS JANSSEN Pharmaceutica NV (BE) 2023-08-02 EP disclosed
CN-116194445-A New compounds 詹森药业有限公司 2023-05-30 CN disclosed
WO-2022063896-A1 NEW COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2022-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240043450-A1 NEW COMPOUND NLRP3, NLRP1, PYCARD ALDH1A1 1954/4885GAA 2907/4885HSD17B10 1598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.